Assessment of bone mineralization following renal transplantation in children: limitations of DXA and the confounding effects of delayed growth and development.
Pediatric renal transplantation recipients have numerous risk factors for decreased bone mass, including the underlying renal disease, nutritional deficits, decreased physical activity, inflammation and exposure to steroid therapy. The assessment of bone mineralization in children following renal transplantation is fraught with difficulty. Dual energy x-ray absorptiometry (DXA) is the most commonly employed tool to assess bone mineralization. However, DXA has important limitations in children and in individuals with renal disease. This brief review will examine the expected gains in bone size and bone mass during growth and the mechanisms by which renal failure and steroid therapy interrupt these process. In addition, the limitations of DXA for detecting impaired bone mineralization in children with renal disease are reviewed and alternative approaches explored.
Leonard
M B
MB
Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA. mleonard@cceb.med.upenn.edu
Bachrach
L K
LK
D015502:Absorptiometry, Photon / Q000379:methods; D015519:Bone Density; D002648:Child; D002658:Developmental Disabilities / Q000209:etiology; D006130:Growth Disorders / Q000209:etiology*; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000145:classification*